ARWR
Price
$16.76
Change
-$2.09 (-11.09%)
Updated
Jul 18 closing price
Capitalization
2.31B
21 days until earnings call
TIL
Price
$25.61
Change
-$0.49 (-1.88%)
Updated
Jul 21, 10:52 AM (EDT)
Capitalization
171.21M
Interact to see
Advertisement

ARWR vs TIL

Header iconARWR vs TIL Comparison
Open Charts ARWR vs TILBanner chart's image
Arrowhead Pharmaceuticals
Price$16.76
Change-$2.09 (-11.09%)
Volume$3.01M
Capitalization2.31B
Instil Bio
Price$25.61
Change-$0.49 (-1.88%)
Volume$100
Capitalization171.21M
ARWR vs TIL Comparison Chart in %
Loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARWR vs. TIL commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARWR is a Hold and TIL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (ARWR: $16.76 vs. TIL: $26.10)
Brand notoriety: ARWR: Notable vs. TIL: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARWR: 190% vs. TIL: 42%
Market capitalization -- ARWR: $2.31B vs. TIL: $171.21M
ARWR [@Biotechnology] is valued at $2.31B. TIL’s [@Biotechnology] market capitalization is $171.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARWR’s FA Score shows that 1 FA rating(s) are green whileTIL’s FA Score has 1 green FA rating(s).

  • ARWR’s FA Score: 1 green, 4 red.
  • TIL’s FA Score: 1 green, 4 red.
According to our system of comparison, both ARWR and TIL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARWR’s TA Score shows that 2 TA indicator(s) are bullish while TIL’s TA Score has 6 bullish TA indicator(s).

  • ARWR’s TA Score: 2 bullish, 5 bearish.
  • TIL’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TIL is a better buy in the short-term than ARWR.

Price Growth

ARWR (@Biotechnology) experienced а -8.47% price change this week, while TIL (@Biotechnology) price change was -2.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

ARWR is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($2.32B) has a higher market cap than TIL($171M). TIL YTD gains are higher at: 36.721 vs. ARWR (-10.851). TIL (-67.77M) and ARWR (-68.12M) have comparable annual earnings (EBITDA) . ARWR has more cash in the bank: 1.1B vs. TIL (104M). TIL has less debt than ARWR: TIL (86.7M) vs ARWR (388M). ARWR has higher revenues than TIL: ARWR (545M) vs TIL (0).
ARWRTILARWR / TIL
Capitalization2.32B171M1,354%
EBITDA-68.12M-67.77M101%
Gain YTD-10.85136.721-30%
P/E RatioN/AN/A-
Revenue545M0-
Total Cash1.1B104M1,055%
Total Debt388M86.7M448%
FUNDAMENTALS RATINGS
ARWR vs TIL: Fundamental Ratings
ARWR
TIL
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
19
Undervalued
PROFIT vs RISK RATING
1..100
10094
SMR RATING
1..100
9697
PRICE GROWTH RATING
1..100
5039
P/E GROWTH RATING
1..100
2100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TIL's Valuation (19) in the Precious Metals industry is significantly better than the same rating for ARWR (94) in the Biotechnology industry. This means that TIL’s stock grew significantly faster than ARWR’s over the last 12 months.

TIL's Profit vs Risk Rating (94) in the Precious Metals industry is in the same range as ARWR (100) in the Biotechnology industry. This means that TIL’s stock grew similarly to ARWR’s over the last 12 months.

ARWR's SMR Rating (96) in the Biotechnology industry is in the same range as TIL (97) in the Precious Metals industry. This means that ARWR’s stock grew similarly to TIL’s over the last 12 months.

TIL's Price Growth Rating (39) in the Precious Metals industry is in the same range as ARWR (50) in the Biotechnology industry. This means that TIL’s stock grew similarly to ARWR’s over the last 12 months.

ARWR's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for TIL (100) in the Precious Metals industry. This means that ARWR’s stock grew significantly faster than TIL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARWRTIL
RSI
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
88%
Aroon
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BFGUX52.830.12
+0.23%
Baron Focused Growth R6
RGLAX26.45-0.03
-0.11%
American Funds Global Insight R-1
AHSCX11.10-0.02
-0.18%
Alger Health Sciences C
LKSCX21.50-0.04
-0.19%
LKCM Small Cap Equity Instl
DHMAX26.33-0.06
-0.23%
Diamond Hill Small-Mid Cap Inv

ARWR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with DNLI. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
-11.09%
DNLI - ARWR
58%
Loosely correlated
-3.65%
IMNM - ARWR
56%
Loosely correlated
+1.24%
RGNX - ARWR
55%
Loosely correlated
-6.10%
BEAM - ARWR
55%
Loosely correlated
+1.47%
YMAB - ARWR
52%
Loosely correlated
-0.23%
More

TIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, TIL has been loosely correlated with SMMT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if TIL jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TIL
1D Price
Change %
TIL100%
-5.78%
SMMT - TIL
54%
Loosely correlated
-5.18%
BNTX - TIL
51%
Loosely correlated
-0.92%
XNCR - TIL
40%
Loosely correlated
-1.10%
DNLI - TIL
36%
Loosely correlated
-3.65%
ARWR - TIL
34%
Loosely correlated
-11.09%
More